Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunomodulation | 2 | 2019 | 253 | 0.960 |
Why?
|
| Monocytes | 8 | 2012 | 787 | 0.950 |
Why?
|
| Dietary Supplements | 3 | 2019 | 570 | 0.880 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 409 | 0.570 |
Why?
|
| Probiotics | 1 | 2019 | 239 | 0.550 |
Why?
|
| beta-Glucans | 2 | 2013 | 35 | 0.510 |
Why?
|
| Immunologic Factors | 1 | 2019 | 671 | 0.510 |
Why?
|
| Physical Conditioning, Animal | 3 | 2012 | 117 | 0.470 |
Why?
|
| Exercise | 4 | 2018 | 1211 | 0.440 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2013 | 687 | 0.330 |
Why?
|
| Weight Loss | 2 | 2012 | 637 | 0.310 |
Why?
|
| Obesity | 4 | 2012 | 2941 | 0.290 |
Why?
|
| Dietary Fats | 3 | 2012 | 350 | 0.250 |
Why?
|
| Bicycling | 3 | 2013 | 45 | 0.230 |
Why?
|
| Leukocyte Count | 2 | 2012 | 740 | 0.180 |
Why?
|
| Weight Gain | 3 | 2012 | 475 | 0.170 |
Why?
|
| Stress, Physiological | 2 | 2013 | 492 | 0.170 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 177 | 0.160 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2012 | 209 | 0.160 |
Why?
|
| Leisure Activities | 1 | 2018 | 17 | 0.150 |
Why?
|
| Toll-Like Receptor 2 | 3 | 2012 | 95 | 0.150 |
Why?
|
| Flow Cytometry | 6 | 2012 | 3079 | 0.140 |
Why?
|
| Immunity, Innate | 2 | 2012 | 688 | 0.140 |
Why?
|
| Physical Exertion | 2 | 2013 | 114 | 0.130 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 2 | 2012 | 19 | 0.120 |
Why?
|
| Common Cold | 1 | 2013 | 35 | 0.110 |
Why?
|
| Animal Feed | 2 | 2010 | 90 | 0.110 |
Why?
|
| Mexican Americans | 2 | 2012 | 328 | 0.110 |
Why?
|
| Immunoglobulin A | 1 | 2013 | 278 | 0.100 |
Why?
|
| CD11a Antigen | 1 | 2012 | 16 | 0.100 |
Why?
|
| B7-2 Antigen | 1 | 2012 | 53 | 0.100 |
Why?
|
| CD18 Antigens | 1 | 2012 | 85 | 0.100 |
Why?
|
| Postprandial Period | 1 | 2012 | 86 | 0.100 |
Why?
|
| Mice, Obese | 1 | 2012 | 99 | 0.100 |
Why?
|
| Adolescent Development | 1 | 2012 | 34 | 0.100 |
Why?
|
| B7-1 Antigen | 1 | 2012 | 86 | 0.100 |
Why?
|
| Diet, Reducing | 1 | 2012 | 85 | 0.100 |
Why?
|
| Adipokines | 1 | 2012 | 99 | 0.100 |
Why?
|
| Chemokine CCL2 | 1 | 2012 | 203 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 2664 | 0.090 |
Why?
|
| Enzymes | 1 | 2011 | 72 | 0.090 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 453 | 0.090 |
Why?
|
| Young Adult | 4 | 2019 | 22014 | 0.090 |
Why?
|
| Child Development | 1 | 2012 | 268 | 0.090 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 243 | 0.090 |
Why?
|
| Longevity | 1 | 2010 | 154 | 0.080 |
Why?
|
| Adolescent | 5 | 2019 | 32578 | 0.080 |
Why?
|
| Exercise Test | 1 | 2010 | 315 | 0.080 |
Why?
|
| Dyslipidemias | 1 | 2012 | 244 | 0.080 |
Why?
|
| Biomarkers | 4 | 2018 | 5105 | 0.080 |
Why?
|
| Cardiovascular Diseases | 3 | 2018 | 2281 | 0.080 |
Why?
|
| Male | 13 | 2019 | 128407 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 912 | 0.080 |
Why?
|
| Adipose Tissue | 1 | 2012 | 734 | 0.080 |
Why?
|
| Texas | 3 | 2012 | 6416 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 1617 | 0.070 |
Why?
|
| Influenza, Human | 1 | 2013 | 759 | 0.070 |
Why?
|
| Double-Blind Method | 1 | 2012 | 2617 | 0.070 |
Why?
|
| Motor Activity | 1 | 2010 | 718 | 0.070 |
Why?
|
| Macrophages | 1 | 2012 | 1369 | 0.070 |
Why?
|
| Cytokines | 2 | 2012 | 2836 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2018 | 6832 | 0.060 |
Why?
|
| Diet | 1 | 2012 | 1489 | 0.060 |
Why?
|
| Adult | 5 | 2019 | 81480 | 0.060 |
Why?
|
| Aging | 1 | 2012 | 1576 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2012 | 5785 | 0.060 |
Why?
|
| Cholesterol, HDL | 2 | 2018 | 368 | 0.060 |
Why?
|
| Mice | 7 | 2012 | 35983 | 0.060 |
Why?
|
| Research Design | 1 | 2010 | 1566 | 0.050 |
Why?
|
| Triglycerides | 2 | 2018 | 619 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2012 | 6022 | 0.050 |
Why?
|
| Liver | 1 | 2011 | 3127 | 0.050 |
Why?
|
| Female | 7 | 2019 | 148432 | 0.050 |
Why?
|
| Blood Glucose | 2 | 2018 | 1288 | 0.040 |
Why?
|
| Reference Standards | 2 | 2012 | 368 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 4180 | 0.040 |
Why?
|
| Animals | 7 | 2012 | 62835 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2013 | 2316 | 0.040 |
Why?
|
| Chicago | 1 | 2018 | 40 | 0.040 |
Why?
|
| Alabama | 1 | 2018 | 47 | 0.040 |
Why?
|
| Minnesota | 1 | 2018 | 126 | 0.040 |
Why?
|
| Waist Circumference | 1 | 2018 | 100 | 0.040 |
Why?
|
| California | 1 | 2018 | 211 | 0.040 |
Why?
|
| Television | 1 | 2018 | 75 | 0.040 |
Why?
|
| Middle Aged | 3 | 2019 | 89908 | 0.040 |
Why?
|
| Fasting | 1 | 2018 | 350 | 0.030 |
Why?
|
| Humans | 7 | 2019 | 270852 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 4506 | 0.030 |
Why?
|
| Linear Models | 1 | 2018 | 1092 | 0.030 |
Why?
|
| Aged | 1 | 2019 | 73012 | 0.030 |
Why?
|
| Running | 1 | 2013 | 43 | 0.030 |
Why?
|
| Risk Factors | 3 | 2018 | 17819 | 0.030 |
Why?
|
| Receptors, Leptin | 1 | 2012 | 68 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2013 | 265 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2012 | 245 | 0.030 |
Why?
|
| Saliva | 1 | 2013 | 238 | 0.030 |
Why?
|
| Cell-Derived Microparticles | 1 | 2012 | 39 | 0.030 |
Why?
|
| Inflammation | 2 | 2012 | 2526 | 0.030 |
Why?
|
| Nutritional Sciences | 1 | 2012 | 68 | 0.020 |
Why?
|
| Zoxazolamine | 1 | 2011 | 2 | 0.020 |
Why?
|
| Immune System | 1 | 2013 | 276 | 0.020 |
Why?
|
| Cytochrome P450 Family 2 | 1 | 2011 | 11 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2018 | 1600 | 0.020 |
Why?
|
| Steroid Hydroxylases | 1 | 2011 | 38 | 0.020 |
Why?
|
| Arylsulfotransferase | 1 | 2011 | 20 | 0.020 |
Why?
|
| Refrigeration | 1 | 2011 | 15 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2012 | 313 | 0.020 |
Why?
|
| Midazolam | 1 | 2011 | 73 | 0.020 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2011 | 91 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 82 | 0.020 |
Why?
|
| Immunity | 1 | 2013 | 356 | 0.020 |
Why?
|
| Edetic Acid | 1 | 2011 | 76 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2011 | 65 | 0.020 |
Why?
|
| Diet, High-Fat | 1 | 2012 | 254 | 0.020 |
Why?
|
| Animal Use Alternatives | 1 | 2010 | 5 | 0.020 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2011 | 88 | 0.020 |
Why?
|
| Glucuronosyltransferase | 1 | 2011 | 106 | 0.020 |
Why?
|
| Animals, Outbred Strains | 1 | 2010 | 15 | 0.020 |
Why?
|
| Blood Specimen Collection | 1 | 2011 | 97 | 0.020 |
Why?
|
| Schools | 1 | 2012 | 236 | 0.020 |
Why?
|
| Housing, Animal | 1 | 2010 | 43 | 0.020 |
Why?
|
| Protein Stability | 1 | 2011 | 374 | 0.020 |
Why?
|
| Reference Values | 1 | 2012 | 1156 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 570 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2011 | 355 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2011 | 917 | 0.020 |
Why?
|
| Body Composition | 1 | 2012 | 609 | 0.020 |
Why?
|
| Heparin | 1 | 2011 | 346 | 0.020 |
Why?
|
| Cholesterol | 1 | 2012 | 679 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2011 | 301 | 0.020 |
Why?
|
| Sleep | 1 | 2011 | 437 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 902 | 0.020 |
Why?
|
| Eating | 1 | 2010 | 449 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 750 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2011 | 639 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2012 | 2108 | 0.020 |
Why?
|
| Body Weight | 1 | 2010 | 1337 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 2049 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 3655 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2010 | 1150 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2012 | 2238 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2011 | 1582 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 6164 | 0.010 |
Why?
|
| Child | 2 | 2012 | 30422 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 5495 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2011 | 2953 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 9036 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 13122 | 0.010 |
Why?
|